Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
139,542,309
-
Total 13F shares
-
75,409,279
-
Share change
-
-3,258,197
-
Total reported value
-
$3,865,770,922
-
Put/Call ratio
-
102%
-
Price per share
-
$51.27
-
Number of holders
-
151
-
Value change
-
-$99,056,866
-
Number of buys
-
73
-
Number of sells
-
87
Institutional Holders of Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR) as of Q1 2021
As of 31 Mar 2021,
Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR) was held by
151 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
75,409,279 shares.
The largest 10 holders included
SB INVESTMENT ADVISERS (UK) LTD, Capital International Investors, VANGUARD GROUP INC, Temasek Holdings (Private) Ltd, BlackRock Inc., BAILLIE GIFFORD & CO, Alaska Permanent Fund Corp, Bill & Melinda Gates Foundation, STATE STREET CORP, and ALLIANCEBERNSTEIN L.P..
This page lists
151
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.